AI-generated summary
In a randomized, double-blind, placebo-controlled trial of 32 adults recovering from mild traumatic brain injury, the authors compared six weeks of daily morning blue light with amber placebo light. They report that blue light was associated with phase-advanced sleep, less daytime sleepiness, better executive functioning, and changes in thalamic volume, connectivity and white matter integrity.
- Participants
- 32
- Who or what was studied
- Adults aged 18 to 48 years with a recent mild traumatic brain injury
- Wavelengths
- 469, 578 nm
- Limits stated in the abstract
- The abstract reports a small sample of 32 adults and does not describe a long-term follow-up or clinical outcomes beyond the measures listed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 469 nm, 578 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Traumatic brain injury, Placebo-controlled, Brain injury, Wavelength, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.